unknown
Stage
About
BioExoTec develops minimally invasive cancer diagnostic tests by analyzing extracellular vesicles in blood and saliva to detect tumor-specific molecular signatures for early cancer detection.
Explore BioExoTec's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.